Health NZ | Te Whatu Ora FHIR Screening Implementation Guide
1.0.1 - normative+trial-use
Health NZ | Te Whatu Ora FHIR Screening Implementation Guide - Local Development build (v1.0.1) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions
As at 06-03-2024
Full Name | Kassandra Temahoe | Date of Birth | 24-11-2008 |
Ethnicity | New Zealand European | NHI Number | ZCU7824 |
Gender | Female | Sex assigned at birth |
Female |
Address | 373 Jackson Street, Petone, Lower Hutt 5012, New Zealand |
Pathway Status | 5 Year Recall | Immune Deficient | No |
Next Expected Event | Eligibility Notification | Total Hysterectomy | No |
Next Event Due Date | 24-11-2033 | Cervical Cancer | No |
Send programme correspondence |
Yes | ||
Unenrolled reason | Patient overseas for 2 years |
Specimen Type | LBC - Liquid based cytology |
Specimen Id | ZKJ2269 |
Site Code | R- Cervical |
Specimen Taker | Mickey Dee |
Requested By Facility | Dr Jane John Surgery |
Received By Facility | Allana Family Planning Clinic |
Adequacy | S1 - The specimen is satisfactory for evaluation |
Interpretation | 02 - There are fungal organisms morphologically consistent with Candida species |
General Category | G1 - CYTOLOGY: NEGATIVE FOR INTRAEPITHELIAL LESION OR MALIGNACY |
Recommendation | H1 - Please recall in three years for HPV primary screening test, or in 12 months if the screening participant is immune deficient |
Grade | N- Negative |
Specimen Type | LBC - Liquid based cytology |
Specimen Id | ZKJ2269 |
Site Code | R- Cervical |
Specimen Taker | Mickey Dee |
Requested By Facility | Dr Jane John Surgery |
Received By Facility | Allana Family Planning Clinic |
Adequacy | S1 - The specimen is satisfactory for evaluation |
Interpretation | 02 - There are fungal organisms morphologically consistent with Candida species |
General Category | G1 - CYTOLOGY: NEGATIVE FOR INTRAEPITHELIAL LESION OR MALIGNACY |
Recommendation | H1 - Please recall in three years for HPV primary screening test, or in 12 months if the screening participant is immune deficient |
Grade | N- Negative |